GENO1®

Better diagnostics
with fewer steps

Transforming sequencing and diagnostics with Geno1®

Background image

The problem

Accessing DNA
should be easier

Our DNA holds the secrets to our health, offering answers that could transform medicine. But right now, getting to this information is slow, complicated, and dependent on expensive infrastructure. We’re here to change that, making it easier, faster, and more affordable to unlock the power of DNA for everyday healthcare and scientific breakthroughs.


the solution

A simpler, faster way to read DNA

Our proprietary circular DNA technology eliminates the barriers of complex and expensive sample processing by enabling DNA to function like a digital database. This innovation makes DNA easier to read and access, transforming healthcare and research with simplicity and efficiency.

  • Portable

    Deploy anywhere, on any sequencing platform, free of infrastructure constraints.

  • Rapid

    Streamlined for modern DNA sequencing platforms, optimized for simplicity.

  • PCR-free

    No need for PCR cleanrooms and associated infrastructure, no contamination.

  • Automated

    Runs on simple liquid handling platforms with minimal hands-on effort.

  • Cost-efficient

    Cut costs by at least 50% compared to market-leading tests.

  • High fidelity

    Minimal processing translates to minimal information distortion.


our technologies

Discover Geno1®

GENO1® TECHNOLOGY
BRIDGE CAPTURE™

Bridge Capture™

High-precision testing for genetics and diagnostics

Discover Bridge Capture™

GENO1® TECHNOLOGY
NICKING LOOP™

Nicking Loop™

Platform-agnostic sequencing to power genomic applications

Discover Nicking Loop™

How it works

Our business model

We operate on a royalty-based out-licensing model. We partner with diagnostic and sequencing platform companies, setting milestones to optimize our technology for each partner’s needs. After meeting these milestones, a royalty-based agreement ensures long-term collaboration.

Diagnostic companies gain cost benefits and portability, while sequencing platforms benefit from improved efficiency and sample preparation. This model enables our partners to enhance their offerings and drive industry innovation.


Get started

Leave us your email and we will be in touch with you.

Please enable JavaScript in your browser to complete this form.
Checkboxes